MCID: CRT033
MIFTS: 35

Corticobasal Degeneration malady

Categories: Genetic diseases, Rare diseases, Neuronal diseases

Aliases & Classifications for Corticobasal Degeneration

About this section

Aliases & Descriptions for Corticobasal Degeneration:

Name: Corticobasal Degeneration 45 46 51 65
Cortical-Basal Ganglionic Degeneration 45
 
Cortico-Basal Ganglionic Degeneration 45
Cbgd 45

Characteristics:

Orphanet epidemiological data:

51
corticobasal degeneration:
Age of onset: Adult

Classifications:



External Ids:

Orphanet51 278
UMLS65 C0393570

Summaries for Corticobasal Degeneration

About this section
NINDS:46 Corticobasal degeneration is a progressive neurological disorder characterized by nerve cell loss and (shrinkage) of multiple areas of the brain including the cerebral cortex and the basal ganglia. Corticobasal degeneration progresses gradually. Initial symptoms, which typically begin at or around age 60, may first appear on one side of the body (unilateral), but eventually affect both sides as the disease progresses. Symptoms are similar to those found in Parkinson disease, such as poor coordination, (an absence of movements), (a resistance to imposed movement), (impaired balance); and limb (abnormal muscle postures). Other symptoms such as cognitive and visual-spatial impairments, apraxia (loss of the ability to make familiar, purposeful movements), hesitant and halting speech, (muscular jerks), and (difficulty swallowing) may also occur. An individual with corticobasal degeneration eventually becomes unable to walk.

MalaCards based summary: Corticobasal Degeneration, also known as cortical-basal ganglionic degeneration, is related to corticobasal degeneration, mapt-related and dementia, frontotemporal. An important gene associated with Corticobasal Degeneration is MAPT (Microtubule Associated Protein Tau), and among its related pathways are Arf6 signaling events and Malaria. Affiliated tissues include cortex, brain and breast, and related mouse phenotypes are no phenotypic analysis and integument.

NIH Rare Diseases:45 Corticobasal degeneration is characterized by the break down (degeneration) of parts of the brain, including the cerebral cortex and basal ganglia. the cerebral cortex is responsible for most of the brain's processing of information, and the basal ganglia are deep brain structures that help start and control movement. signs and symptoms of corticobasal degeneration include poor coordination, loss of movement, rigidity, poor balance, unnatural posturing of the muscles, intellectual (cognitive) impairment, speech impairment, muscular jerks, and difficulty swallowing. these symptoms develop and worsen over time. currently the cause of corticobasal degeneration is not known. last updated: 5/14/2015

Wikipedia:68 Corticobasal degeneration (CBD) or corticobasal ganglionic degeneration (CBGD) is a rare, progressive... more...

Related Diseases for Corticobasal Degeneration

About this section

Graphical network of the top 20 diseases related to Corticobasal Degeneration:



Diseases related to corticobasal degeneration

Symptoms for Corticobasal Degeneration

About this section

Drugs & Therapeutics for Corticobasal Degeneration

About this section

Drugs for Corticobasal Degeneration (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 22)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1cadexomer iodinePhase 4456
2Pharmaceutical SolutionsPhase 47004
3
IodinePhase 44947553-56-2807
Synonyms:
I2
Iode
Iodine-molecule
 
Iodio
Iodum
Jod
Jood
Tincture iodine
4CalamusNutraceuticalPhase 4344
5VitaminsPhase 2, Phase 33857
6UbiquinonePhase 2, Phase 392
7Trace ElementsPhase 2, Phase 33900
8MicronutrientsPhase 2, Phase 33901
9
Coenzyme Q10NutraceuticalPhase 2, Phase 3104303-98-05281915
Synonyms:
(all-E)-2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaenyl)-2,5-Cyclohexadiene-1,4-dione
(all-E)-2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-Cyclohexadiene-1,4-dione
2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-Benzoquinone
2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl- 2,5-Cyclohexadiene-1,4-dione
4-Ethyl-5-fluoropyrimidine
Aqua Q 10L10
Aqua Q10
Bio-Quinon
Bio-Quinone Q10
CoQ10
Coenzyme Q10
Ensorb
Kaneka Q10
Kudesan
 
Li-Q-Sorb
Liquid-Q
Neuquinon
Neuquinone
PureSorb Q 40
Q 10AA
Q-Gel
Q-Gel 100
Ubidecarenone
Ubiquinone 10
Ubiquinone 50
Ubiquinone Q10
Ubiquinone-10
Unbiquinone
Unispheres Q 10
10
QuinidineapprovedPhase 24156-54-2441074
Synonyms:
(+)-quinidine
(-)-Quinine
(8R,9S)-Quinidine
(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol
(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol
(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol
11010-73-4
12239-42-8
128544-03-6
130-89-2
130-95-0
1407-83-6
21480-31-9
22600_FLUKA
22620_FLUKA
22620_SIGMA
50-54-4
500225-45-6
549-56-4
55980-20-6
56-54-2
572-59-8
6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol
6119-70-6
6151-39-9
6151-40-2
6183-68-2
6591-63-5
6912-57-8
72646-90-3
767303-40-2
804-63-7
840482-04-4
845886-64-8
857212-53-4
864908-93-0
875538-34-4
882741-47-1
883881-01-4
888714-03-2
890027-24-4
894767-09-0
898813-59-7
898814-00-1
898814-28-3
899813-83-3
900786-66-5
900789-95-9
906550-97-8
909263-47-4
909767-48-2
909882-78-6
910878-25-0
910880-97-6
910899-51-3
911445-75-5
918778-04-8
AB00514657
AC1L199L
AC1L1ANE
AC1L1LHL
AC1L1R7Y
AC1L3RNZ
AC1L9AHT
AC1L9AHW
AC1LCUGN
AC1LDI43
AC1LDI46
AC1MBNAI
AC1MHDEF
AC1MHUCH
AC1MHWS7
AC1MI1Q5
AC1NSV55
AC1NSV58
AC1NSZYR
AC1NSZYU
AC1NUNML
AC1NUNMO
AC1NX8JM
AC1O56R7
AC1O7EE0
AC1O7GNZ
AC1OAH7Z
AC1OCD5W
AC1OCD62
AC1OFCPL
AC1Q4EZ5
AC1Q4EZ6
AC1Q58AF
AR-1A4833
AR-1H2065
Aflukin
Apo-Quinidine
Auriquin
BB_NC-0697
BIB1110
BIDD:GT0144
Biquin Durules
C06526
C06527
C20H24N2O2
CCRIS 5755
CCRIS 672
CHEBI:111177
CHEBI:15854
CHEBI:28593
CHEMBL170
CHEMBL21578
CHEMBL576997
CHEMBL601807
CHEMBL97
CID10448938
CID1065
CID25522
CID2728270
CID3000825
CID3032576
CID3034034
CID3036746
CID441073
CID441074
CID5317111
CID5317112
CID5320867
CID5320868
 
CID5484444
CID5484450
CID5748152
CID5953
CID637552
CID6453100
CID6602154
CID6604605
CID667448
CID667449
CID6857801
CID6916033
CID6916036
CID7048767
CID8549
CID94175
CID9967055
CIN-QUIN
CPD000857275
Cardioquin
Chinidin
Chinidine
Chinidinum
Chinin
Chinine
Cin-Quin
Coccinine
Coco-Quinine
Conchinin
Conchinine
Conquinine
D08458
D08460
DB00468
DB00908
Duraquin
Epiquinidine
FT-0082277
GNF-PF-5459
GNF-Pf-180
GNF-Pf-5423
HMS1304I22
HMS1607A11
HMS1989J09
HMS2089E05
HSDB 225
HSDB 2501
I14-3348
I14-3397
IBS-L0034250
IDI1_000134
KBio1_000134
KBio2_001392
KBio2_003960
KBio2_006528
KBio3_001551
KST-1A1085
Kinidin
Kinidin (TN)
L001278
LS-141252
LS-187236
LS-194958
LS-221
LS-4562
LT00645788
Lopac-Q-0875
Lopac-Q-1250
MLS001304041
MLS001335913
MLS001335914
NCI-C56246
NCI60_004320
NINDS_000134
NSC 192949
NSC 5362
NSC131458
NSC192949
NSC5362
NSC667852
Novoquinidin
OR28880
Pitayin
Pitayine
Q0006
Q3625_SIGMA
Quin-Release
Quinact
Quinaglute
Quinaglute Dura-Tabs
Quinalan
Quinate
Quinatime
Quindan
Quindine
Quinicardine
Quinidex
Quinidex Extentabs
Quinidina
Quinidine
Quinidine Gluconate
Quinidine Sulfate
Quiniduran
Quinimax
Quinine
Quinine Dab
Quinora
Quniacridine
RH01857
SAM002264644
SB01652
SMP1_000254
SMR000718748
SMR000857275
SPBio_001375
SPBio_002379
ST056282
TCMDC-131239
TNP00086
alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol
beta-Quinine
bmse000511
chinidinum
chininum
quinidina
quinidine
quinina
β-quinine
11
DextromethorphanapprovedPhase 2122125-71-35360696, 5362449
Synonyms:
( )-3-Methoxy-N-methylmorphinon
( )-cis-1,3,4,9,10,10a-Hexahydro-6-methoxy-11-methyl-2H-10,4alpha-iminoethanophenanthren
(+)-3-Methoxy-17-methylmorphinan
(-)-3-Methoxy-N-methylmorphinan
(9alpha,13alpha,14alpha)-17-methyl-3-(methyloxy)morphinan
125-69-9 (hydrobromide)
125-70-2
125-71-3
18046-32-7
18609-21-7 (hydrochloride)
3-Methoxy-17-methyl-9alpha,13alpha,14alpha-morphinan
3-Methoxy-17-methylmorphinan
32062-10-5
4-21-00-01367 (Beilstein Handbook Reference)
6700-34-1 (hydrobromide, mono-hydrate)
9alpha,13alpha,14alpha-Morphinan, 3-methoxy-17-methyl- (8CI)
AC-13098
AC1L1EYT
Albutussin
Antussan
BA 2666
BPBio1_000503
BRD-K33211335-337-03-7
BRN 0088549
BSPBio_000457
Balminil DM
Balminil DM Children
Bayer Select Flu Relief
Bayer Select Head & Chest Cold
Bayer Select Night Time Cold
Benylin Adult Formula Cough Suppressant
Benylin DM
Benylin DM (TN)
Benylin DM 12 Hour
Benylin DM for Children
Benylin DM for Children 12 Hour
Benylin Pediatric Cough Suppressant
C06947
CHEBI:128891
CHEBI:4470
CHEBI:580686
CHEMBL22207
CHEMBL52440
CID3008
CID5360696
CID5362449
Calmylin #1
Canfodion
Cerose-DM
Chloraseptic DM
Contac Day & Night Cold/Flu Day Caplets
Contac Jr. Non-drowsy Formula
Contac Nighttime Cold Medicine
Contac Severe Cold Formula Maximum Strength
Contac Severe Cold Formula Non-Drowsy
Coricidin Syrup
Cosylan
Cough Medicine soothing relief
Cough-X
Creo-Terpin
D-Methorphan
D-Methorphan Hydrobromide
D03742
DB00514
DEA No. 9210
DM
DMHM
DXM
Delsym
Delsym (dextromethorphan)
Delsym Cough Formula
Delta-Methorphan
Demorphan
Demorphan Hydrobromide
Demorphan hydrobromide
Demorphine
Destrometerfano
Destrometerfano [DCIT]
Destrometerfano [Dcit]
Dextromethorfan
Dextromethorfan [Czech]
Dextromethorphan
Dextromethorphan (USP)
Dextromethorphan Bromhydrate
Dextromethorphan Bromide
Dextromethorphan Hydrobromide
Dextromethorphan [USP:INN:BAN]
Dextromethorphan hydrobromide
Dextromethorphan hydrobromide OROS Tablets
Dextromethorphan hydrobromide [BAN:JAN]
Dextromethorphan hydrobromide monohydrate
Dextromethorphane
Dextromethorphane [INN-French]
Dextromethorphanum
Dextromethorphanum [INN-Latin]
Dextrometorfano
Dextrometorfano [INN-Spanish]
Dextrometorphan
Dextromorphan
Dextrométhorphane
Dexyromethorphan
 
Diabe-Tuss DM Syrup
Dimacol
Dimetapp DM
Dormetan
Dormethan
Drixoral Cough
Drixoral Cough & Congestion
Drixoral Cough & Sore Throat
EINECS 204-751-7
EINECS 204-752-2
Endotussin-NN
Endotussin-NN Pediatric
HMS2090C08
HSDB 3056
Hihustan M.
Hold
Hold DM
Koffex DM
L-Methorphan
LS-91837
LS-91838
Levomethorphan
Levomethorphan [BAN:DCF:INN]
Levomethorphan [Ban:Dcf:Inn]
Levomethorphan [INN:BAN:DCF]
Levomethorphane
Levomethorphane [INN-French]
Levomethorphanum
Levomethorphanum [INN-Latin]
Levometorfano
Levometorfano [INN-Spanish]
Lopac-D-2531
Lopac0_000337
MLS000758303
Medicon
Methorate
Methorate Hydrobromide
Methorphan
Metrorat
Mielim Y Mas
MolPort-003-940-943
MolPort-004-285-957
Morphinan, 3-methoxy-17-methyl-, (9-alpha,13-alpha,14-alpha)- (9CI)
NCGC00015333-01
NCGC00015333-02
NCGC00015333-04
NCGC00162126-01
Naldecon-DX
Novahistex DM
Novahistine DM
Ornex Severe Cold Formula
Orthoxicol
PediaCare 1
PediaCare Cough-Cold Formula
Pertussin CS Children's Strength
Pertussin DM Extra Strength
Prestwick0_000359
Prestwick1_000359
Prestwick2_000359
Prestwick3_000359
Prestwick_686
RACEMETHORPHAN
Robitussin CF
Robitussin Cold & Cough
Robitussin Cough Calmers
Robitussin DM
Robitussin Maximum Strength Cough
Robitussin Maximum Strength Cough Suppressant
Robitussin Pediatric
Robitussin Pediatric Cough
Robitussin Pediatric Cough & Cold
Robitussin Pediatric Cough Suppressant
Robitussin Pediatric Night Relief
Romilar
Rondec dm
Ru-Tuss Expectorant
SPBio_002378
St. Joseph Cough Syrup
Sucrets 4 Hour Cough Suppressant
Sudafed Cough Syrup
Triaminic
Triaminic DM Long Lasting for Children
Trind-DM
Trocal
Tusilan
Tussade
Tussar DM
Tussi-Organidin
Tussi-Organidin DM NR
Tussi-Organidin DM-S NR
Tylenol Cold No Drowsiness
Tylenol Cold and Flu Multi-Symptom
Tylenol Cold and Flu No Drowsiness
Tylenol Cough + Decongestant Liquid
Tylenol Cough Liquid
Tylenol Flu No Drowsiness Gelcaps
UNII-7355X3ROTS
Vicks 44 Cough Relief
Viro-Med
d-Methorphan
delta-Methorphan
dextromethorphan
l-Methorphan
12Fluorodeoxyglucose F18Phase 2356
13RadiopharmaceuticalsPhase 2362
14Tranquilizing AgentsPhase 1, Phase 23597
15Antimanic AgentsPhase 1, Phase 2663
16Psychotropic DrugsPhase 1, Phase 25501
17Central Nervous System DepressantsPhase 1, Phase 210016
18Antidepressive AgentsPhase 1, Phase 22367
19Lithium CarbonatePhase 1, Phase 2211
20Quinidine gluconatePhase 241
21Tubulin ModulatorsPhase 14279
22taxanePhase 1324

Interventional clinical trials:

(show all 20)
idNameStatusNCT IDPhase
1DaTSCAN Imaging in Aging and Neurodegenerative DiseaseEnrolling by invitationNCT01453127Phase 4
2Effects of Coenzyme Q10 in PSP and CBDCompletedNCT00532571Phase 2, Phase 3
3A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal DegenerationCompletedNCT00703677Phase 1, Phase 2
4The Differential Diagnosis of Parkinson's Disease and Parkinsonism by Positron-emission TomographyCompletedNCT01824056Phase 2
5Electrical Polarization of the Brain in Corticobasal SyndromeCompletedNCT00273897Phase 2
6Davunetide (AL-108) in Predicted Tauopathies - Pilot StudyActive, not recruitingNCT01056965Phase 2
7Safety, Tolerability and Efficacy of AVP-786 for the Treatment of DisinhibitionNot yet recruitingNCT02534038Phase 2
8Safety Study of TPI-287 to Treat CBS and PSPRecruitingNCT02133846Phase 1
9Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy VolunteersActive, not recruitingNCT02167594Phase 1
10Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal DegenerationCompletedNCT01174771
11Study of Tongue PressuresCompletedNCT00013832
124 Repeat Tauopathy Neuroimaging InitiativeRecruitingNCT01804452
13PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UKRecruitingNCT02778607
14Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)RecruitingNCT02365922
15Study for the Early Diagnosis of Parkinson's DiseaseRecruitingNCT02283073
16Parkinson's Disease, Diagnostic Observations (PADDO)RecruitingNCT01249768
17Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders, PD,Essential Tremor, (ET),Cortical Basal Degeneration, (CBD),Multiple Systems Atrophy (MSA), MagnetoencephalographyActive, not recruitingNCT02132052
18The Sunnybrook Dementia Study: Mapping Brain Changes in Alzheimer's, Vascular and Other DementiasActive, not recruitingNCT01800214
19Innovative Biomarkers in Alzheimer's Disease and Frontotemporal Dementia (FTD): Preventative and PersonalizedNot yet recruitingNCT01403519
20SudoScan as a Biomarker of Parkinson's DiseaseNot yet recruitingNCT02767037

Search NIH Clinical Center for Corticobasal Degeneration

Genetic Tests for Corticobasal Degeneration

About this section

Anatomical Context for Corticobasal Degeneration

About this section

MalaCards organs/tissues related to Corticobasal Degeneration:

33
Cortex, Brain, Breast, Tongue, T cells, Lung, Liver

Animal Models for Corticobasal Degeneration or affiliated genes

About this section

MGI Mouse Phenotypes related to Corticobasal Degeneration:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00030128.7CFL1, KIF13B, MAPT, PITX3, SOS1, TARDBP
2MP:00107718.5CFL1, CSF3, GBA, MAPT, PITX3, SOS1
3MP:00053867.6CFL1, GBA, HSPB2, MAPT, MOBP, PITX3
4MP:00036317.2CFL1, GBA, HSPB2, MAPT, MOBP, PITX3

Publications for Corticobasal Degeneration

About this section

Articles related to Corticobasal Degeneration:

(show top 50)    (show all 391)
idTitleAuthorsYear
1
Haplotypes at LBX1 have distinct inheritance patterns with opposite effects in adolescent idiopathic scoliosis. (25675428)
2015
2
Group A streptococcal endophthalmitis complicating a sore throat in a 2-year-old child. (25858925)
2015
3
MicroRNA-10a silencing reverses cisplatin resistance in the A549/cisplatin human lung cancer cell line via the transforming growth factor-I^/Smad2/STAT3/STAT5 pathway. (25586740)
2015
4
Constrictive pericarditis--a curable diastolic heart failure. (25072910)
2014
5
MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1. (24642628)
2014
6
Ameloblastoma: demographic data and treatment outcomes from Melbourne, Australia. (25329538)
2014
7
SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner. (24496038)
2014
8
The contribution of psychological factors to recovery after mild traumatic brain injury: Is cluster analysis a useful approach? (25409487)
2014
9
Total antioxidant capacity of saliva and dental caries. (23524431)
2013
10
Chronic Hepatitis E as a cause for cryptogenic cirrhosis in HIV. (22166370)
2013
11
Sex differences in the incidence of chronic myeloid leukemia. (24337217)
2013
12
Tumor necrosis factor-alpha promoter polymorphisms are associated with idiopathic primary ovarian insufficiency in Korean women. (22884017)
2012
13
An epidemiological model of Rift Valley fever with spatial dynamics. (22924058)
2012
14
Endoscopic extracapsular removal of pituitary adenoma: the importance of pretreatment of an adjacent unruptured internal carotid artery aneurysm. (23119196)
2012
15
Atypical variants of classic achalasia are common and currently under-recognized: a study of prevalence and clinical features. (21435920)
2011
16
Human papilloma virus infection in female kidney transplant recipients. (21566296)
2011
17
The neural substrates of rapid-onset Dystonia-Parkinsonism. (21297628)
2011
18
CBL mutation in childhood therapy-related leukemia. (21494262)
2011
19
A mutation in the RNF170 gene causes autosomal dominant sensory ataxia. (21115467)
2011
20
Development of fatal acute liver failure in HIV-HBV coinfected patients. (20731028)
2010
21
Novel therapeutics for melanoma. (19496721)
2009
22
Genotype-phenotype correlations for exudative age-related macular degeneration associated with homozygous HTRA1 and CFH genotypes. (18362109)
2008
23
L-FABP T94A is associated with fasting triglycerides and LDL-cholesterol in women. (17485234)
2007
24
Intraoperative hypokalemia in pediatric liver transplantation: incidence and risk factors. (16931666)
2006
25
Contribution of N-linked glycans to the conformation and function of intercellular adhesion molecules (ICAMs). (15545280)
2005
26
Functional assay of effectors of ADP ribosylation factor 6 during clathrin/AP-2 coat recruitment to membranes. (16413285)
2005
27
Genetic and environmental components of adolescent adjustment and parental behavior: a multivariate analysis. (16150005)
2005
28
Human plasma ghrelin levels increase during a one-year exercise program. (15585547)
2005
29
Modulation of cardiac sodium channel gating by protein kinase A can be altered by disease-linked mutation. (14500710)
2003
30
Molecular mechanisms of reduced sarcoplasmic reticulum Ca(2+) uptake in human failing left ventricular myocardium. (11897526)
2002
31
Compartment analysis of T cell receptor gamma--and immunoglobulin V(H) rearrangements by microdissection in patients with malt lymphoma and chronic gastritis with lymphatic hyperplasia. (12030429)
2002
32
N-terminal residues regulate the catalytic efficiency of the Hsp90 ATPase cycle. (12235160)
2002
33
Animal models of Salmonella infections: enteritis versus typhoid fever. (11755423)
2001
34
Three novel deletions in the alanine:glyoxylate aminotransferase gene of three patients with type 1 hyperoxaluria. (11708860)
2001
35
Binding of levosimendan, a calcium sensitizer, to cardiac troponin C. (11113122)
2001
36
Secretion of gelatinases and activation of gelatinase A (MMP-2) by human rheumatoid synovial fibroblasts. (11727833)
2001
37
Protein kinase CK2 signal in neoplasia. (11332713)
2001
38
MAGE-11 protein is highly conserved in higher organisms and located predominantly in the nucleus. (9495246)
1998
39
Detection of cytokine mRNA-expressing cells in peripheral blood of patients with IgA nephropathy using non-radioactive in situ hybridization. (8565271)
1996
40
Radiation-induced meningioma in children: report of two cases and review of the literature. (8753667)
1996
41
Exclusion of primary congenital glaucoma (buphthalmos) from two candidate regions of chromosome arm 6p and chromosome 11. (8741877)
1996
42
The retinoblastoma susceptibility gene product regulates Myc-mediated transcription. (7838535)
1995
43
Metabolic diversity of regulating liver lactate dehydrogenase and alcohol dehydrogenase in intact animals]. (7620144)
1995
44
Prevalence of antibodies to hepatitis C virus (anti-HCV) in different populations in Taiwan. (1657545)
1991
45
Polycystic ovary syndrome: evolution of a concept. (1813001)
1991
46
Autistic disorder in Sotos syndrome: a case report. (2347353)
1990
47
Central neurocytoma--case report. (1697045)
1990
48
De Barsy syndrome--an autosomal recessive, progeroid syndrome. (4076251)
1985
49
Calcified intraluminal meconium in newborn males with imperforate anus. Enterolithiasis in the newborn. (1200245)
1975
50
BILATERAL TESTICULAR TUMORS: SPINDLE CELL SARCOMA AND SEMINOMA; CASE REPORT. (14044197)
1963

Variations for Corticobasal Degeneration

About this section

Expression for genes affiliated with Corticobasal Degeneration

About this section
Search GEO for disease gene expression data for Corticobasal Degeneration.

Pathways for genes affiliated with Corticobasal Degeneration

About this section

Pathways related to Corticobasal Degeneration according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.7KIF13B, SOS1
29.5CSF3, SOS1

GO Terms for genes affiliated with Corticobasal Degeneration

About this section

Sources for Corticobasal Degeneration

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet